MCID: URT013
MIFTS: 19

Ureter Small Cell Carcinoma malady

Categories: Cancer diseases

Aliases & Classifications for Ureter Small Cell Carcinoma

Aliases & Descriptions for Ureter Small Cell Carcinoma:

Name: Ureter Small Cell Carcinoma 12 14 69
Ureteral Small Cell Carcinoma 12

Classifications:



External Ids:

Disease Ontology 12 DOID:6886
NCIt 47 C6176
UMLS 69 C1336878

Summaries for Ureter Small Cell Carcinoma

MalaCards based summary : Ureter Small Cell Carcinoma, also known as ureteral small cell carcinoma, is related to peroneal nerve paralysis and thymus small cell carcinoma, and has symptoms including flank pain An important gene associated with Ureter Small Cell Carcinoma is CHGA (Chromogranin A). The drugs Fentanyl and Cisplatin have been mentioned in the context of this disorder.

Related Diseases for Ureter Small Cell Carcinoma

Diseases related to Ureter Small Cell Carcinoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 74)
id Related Disease Score Top Affiliating Genes
1 peroneal nerve paralysis 10.0 CHGA SYP
2 thymus small cell carcinoma 10.0 CHGA SYP
3 brain stem ependymoma 10.0 CHGA SYP
4 non specific chronic endometritis 10.0 CHGA SYP
5 extrahepatic biliary papillomatosis 10.0 CHGA SYP
6 prolactin producing pituitary tumor 10.0 CHGA SYP
7 epithelioid malignant peripheral nerve sheath tumor 10.0 CHGA SYP
8 cartilage cancer 10.0 CHGA SYP
9 villous adenocarcinoma 10.0 CHGA SYP
10 jejunal neuroendocrine tumor 10.0 CHGA SYP
11 renal pelvis adenocarcinoma 10.0 CHGA SYP
12 spasmodic dysphonia 10.0 CHGA SYP
13 barre-lieou syndrome 10.0 CHGA SYP
14 microinvasive cervical squamous cell carcinoma 10.0 CHGA SYP
15 perineural angioma 10.0 CHGA SYP
16 gastric duplication cysts 10.0 CHGA SYP
17 diffuse cutaneous mastocytosis 10.0 CHGA SYP
18 main bronchus cancer 10.0 CHGA SYP
19 gliofibroma 10.0 CHGA SYP
20 cavernous hemangioma of face 10.0 CHGA SYP
21 adult botryoid rhabdomyosarcoma 10.0 CHGA SYP
22 superior vena cava syndrome 10.0 CHGA SYP
23 exudative glomerulonephritis 10.0 CHGA SYP
24 fragile x-associated tremor/ataxia syndrome 10.0 CHGA SYP
25 hepatorenal syndrome 10.0 CHGA SYP
26 acalculous cholecystitis 10.0 CHGA SYP
27 piussan lenaerts mathieu syndrome 10.0 CHGA SYP
28 brain stem astrocytic neoplasm 10.0 CHGA SYP
29 anal squamous cell carcinoma 10.0 CHGA SYP
30 uterine corpus myxoid leiomyosarcoma 10.0 CHGA SYP
31 calcific tendinitis 10.0 CHGA SYP
32 mitochondrial complex ii deficiency 10.0 CHGA SYP
33 bone marrow cancer 10.0 CHGA SYP
34 dysgerminoma of ovary 10.0 CHGA SYP
35 pediculus humanus corporis infestation 10.0 CHGA SYP
36 acinar cell cystadenocarcinoma 10.0 CHGA SYP
37 hunter macpherson syndrome 10.0 CHGA SYP
38 cowden syndrome 3 10.0 CHGA SYP
39 ampulla of vater mucinous adenocarcinoma 10.0 CHGA SYP
40 thymus squamous cell carcinoma 10.0 CHGA SYP
41 growth retardation hydrocephaly lung hypoplasia 10.0 CHGA SYP
42 testicular trophoblastic tumor 10.0 CHGA SYP
43 bone dysplasia azouz type 10.0 CHGA SYP
44 cardioauditory syndrome of sanchez cascos 10.0 CHGA SYP
45 pancreatic agenesis 10.0 CHGA SYP
46 eccrine papillary adenocarcinoma 10.0 CHGA SYP
47 vaginal villous adenoma 10.0 CHGA SYP
48 t-cell adult acute lymphocytic leukemia 10.0 CHGA SYP
49 clear cell variant infiltrating bladder urothelial carcinoma 10.0 CHGA SYP
50 myoepithelial carcinoma 10.0 CHGA SYP

Graphical network of the top 20 diseases related to Ureter Small Cell Carcinoma:



Diseases related to Ureter Small Cell Carcinoma

Symptoms & Phenotypes for Ureter Small Cell Carcinoma

UMLS symptoms related to Ureter Small Cell Carcinoma:


flank pain

Drugs & Therapeutics for Ureter Small Cell Carcinoma

Drugs for Ureter Small Cell Carcinoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 108)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 3 437-38-7 3345
2
Cisplatin Approved Phase 3,Phase 2,Phase 1 15663-27-1 84093 441203 2767
3
Gemcitabine Approved Phase 3,Phase 2,Phase 1 95058-81-4 60750
4
Paclitaxel Approved, Vet_approved Phase 3,Phase 2,Phase 1 33069-62-4 36314
5
Succinylcholine Approved Phase 3,Phase 2 306-40-1 5314
6
Bevacizumab Approved, Investigational Phase 3 216974-75-3
7 Liver Extracts Phase 3,Phase 2,Phase 1
8 Anti-Infective Agents Phase 3,Phase 2,Phase 1
9 Antiviral Agents Phase 3,Phase 2,Phase 1
10 Adjuvants, Anesthesia Phase 3
11 Analgesics Phase 3
12 Analgesics, Opioid Phase 3
13 Anesthetics Phase 3
14 Anesthetics, General Phase 3
15 Anesthetics, Intravenous Phase 3
16 Central Nervous System Depressants Phase 3
17 Narcotics Phase 3
18 pancreatic polypeptide Phase 3,Phase 1
19 Peripheral Nervous System Agents Phase 3,Phase 2
20 Albumin-Bound Paclitaxel Phase 3,Phase 2,Phase 1
21 Antimetabolites Phase 3,Phase 2,Phase 1
22 Antimetabolites, Antineoplastic Phase 3,Phase 2,Phase 1
23 Antimitotic Agents Phase 3,Phase 2,Phase 1
24 Antineoplastic Agents, Phytogenic Phase 3,Phase 2,Phase 1
25 Immunosuppressive Agents Phase 3,Phase 2,Phase 1
26 Angiogenesis Inhibitors Phase 3,Phase 1
27 Angiogenesis Modulating Agents Phase 3,Phase 1
28 Antibodies Phase 3,Phase 2,Phase 1
29 Antibodies, Monoclonal Phase 3,Phase 2,Phase 1
30 Immunoglobulins Phase 3,Phase 2,Phase 1
31 Neuromuscular Agents Phase 3,Phase 2
32 Neuromuscular Blocking Agents Phase 3,Phase 2
33 Neuromuscular Depolarizing Agents Phase 3,Phase 2
34 Endothelial Growth Factors Phase 3
35 Immunoglobulin G Phase 3
36 Mitogens Phase 3
37 Cola Nutraceutical Phase 3,Phase 2,Phase 1
38
Indinavir Approved Phase 2 150378-17-9 5362440
39
Ritonavir Approved, Investigational Phase 2 155213-67-5 392622
40
Irinotecan Approved, Investigational Phase 2 97682-44-5, 100286-90-6 60838
41
Gefitinib Approved, Investigational Phase 2 184475-35-2 123631
42
Doxorubicin Approved, Investigational Phase 2 23214-92-8 31703
43
Lenograstim Approved Phase 2 135968-09-1
44
Carboplatin Approved Phase 2,Phase 1 41575-94-4 10339178 498142 38904
45
Trastuzumab Approved, Investigational Phase 2,Phase 1 180288-69-1 9903
46
Benzocaine Approved Phase 2 1994-09-7, 94-09-7 2337
47
nivolumab Approved Phase 2,Phase 1 946414-94-4
48
Methotrexate Approved Phase 2 1959-05-2, 59-05-2 126941
49
Vinblastine Approved Phase 2 865-21-4 13342 241903
50
Dexamethasone Approved, Investigational, Vet_approved Phase 2 50-02-2 5743

Interventional clinical trials:

(show all 30)
id Name Status NCT ID Phase
1 Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain Completed NCT00538850 Phase 3
2 Cisplatin Plus Gemcitabine With or Without Paclitaxel in Treating Patients With Stage IV Urinary Tract Cancer Completed NCT00022191 Phase 3
3 Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer Active, not recruiting NCT00942331 Phase 3
4 External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases Unknown status NCT00637637 Phase 2
5 S0306, Irinotecan in Treating Patients With Recurrent or Refractory Advanced Transitional Cell Cancer of the Urothelium Previously Treated With Chemotherapy Completed NCT00066612 Phase 2
6 S0031, ZD 1839 in Treating Patients With Advanced Cancer of the Urinary Tract Completed NCT00014144 Phase 2
7 Gemcitabine, Paclitaxel, Doxorubicin in Metastatic or Unresectable Bladder Cancer With Decreased Kidney Function Completed NCT00478361 Phase 2
8 Trastuzumab and Combination Chemotherapy in Treating Patients With Locally Recurrent or Metastatic Urinary Tract Cancer Completed NCT00005831 Phase 2
9 Gefitinib Plus Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Bladder Cancer Completed NCT00041106 Phase 2
10 TRC105 in Adults With Advanced/Metastatic Urothelial Carcinoma Completed NCT01328574 Phase 2
11 Nivolumab and Ipilimumab in Treating Patients With Rare Tumors Recruiting NCT02834013 Phase 2
12 Cisplatin and Gemcitabine Hydrochloride With or Without ATR Kinase Inhibitor VX-970 in Treating Patients With Metastatic Urothelial Cancer Recruiting NCT02567409 Phase 2
13 Chemotherapy Before Surgery in Treating Patients With High Grade Upper Urinary Tract Cancer Recruiting NCT02412670 Phase 2
14 A Trial to Evaluate Pemetrexed Clinical Responses in Relation to Tumor MTAP Gene Status in Patients With Previously Treated Metastatic Urothelial Carcinoma Recruiting NCT02693717 Phase 2
15 Gemcitabine Hydrochloride and Eribulin Mesylate in Treating Patients With Bladder Cancer That is Advanced or Cannot Be Removed by Surgery Active, not recruiting NCT02178241 Phase 2
16 Eribulin Mesylate in Treating Patients With Locally Advanced or Metastatic Cancer of the Urothelium and Kidney Dysfunction Active, not recruiting NCT00365157 Phase 1, Phase 2
17 Trastuzumab in Treating Patients With Previously Treated, Locally Advanced, or Metastatic Cancer of the Urothelium Terminated NCT00004856 Phase 2
18 Clinical Trial Of Neoadjuvant Chemotherapy (NAC)In Upper Tract Urothelial Carcinoma (UTUC) Terminated NCT01663285 Phase 2
19 S0028, Gemcitabine and Paclitaxel in Treating Patients With Advanced or Recurrent Cancer of the Urinary Tract Terminated NCT00022633 Phase 2
20 MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma Completed NCT00020579 Phase 1
21 Thalidomide and Docetaxel in Treating Patients With Advanced Cancer Completed NCT00049296 Phase 1
22 Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu Completed NCT00004074 Phase 1
23 Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer Completed NCT00005842 Phase 1
24 Cabozantinib-s-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors Recruiting NCT02496208 Phase 1
25 Pembrolizumab and Docetaxel or Gemcitabine Hydrochloride in Treating Patients Urothelial Cancer Recruiting NCT02437370 Phase 1
26 Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction Recruiting NCT01366144 Phase 1
27 Veliparib, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Advanced Biliary, Pancreatic, Urothelial, or Non-Small Cell Lung Cancer Terminated NCT01282333 Phase 1
28 Early Intervention vs. Standard Palliative Care in Improving End-of-Life Care in Advanced Cancer Patients Completed NCT00253383
29 Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung Cancers Recruiting NCT01846520
30 Integrated Cancer Repository for Cancer Research Recruiting NCT02012699

Search NIH Clinical Center for Ureter Small Cell Carcinoma

Genetic Tests for Ureter Small Cell Carcinoma

Anatomical Context for Ureter Small Cell Carcinoma

Publications for Ureter Small Cell Carcinoma

Variations for Ureter Small Cell Carcinoma

Expression for Ureter Small Cell Carcinoma

Search GEO for disease gene expression data for Ureter Small Cell Carcinoma.

Pathways for Ureter Small Cell Carcinoma

GO Terms for Ureter Small Cell Carcinoma

Sources for Ureter Small Cell Carcinoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....